RBC Bioscience Corporation
6848
Rank in Stocks
#29117
RBC Bioscience Corporation is a firm dedicated to the research, development,... RBC Bioscience Corporation is a firm dedicated to the research, development, production, and sale of specialized reagents and advanced equipment. These products cater to the life sciences and molecular diagnostic sectors. Its market reach is extensive, covering Europe, the United States, Asia, Taiwan, Africa, and Australia. The company's diverse product line includes reagents tailored for molecular biomedical diagnostics and scientific research, alongside automated instruments for gene and nucleic acid extraction. It also provides a range of nucleic acid extraction kits and associated reagent tissues. Sales are primarily conducted through a global network of distributors. Established in 1995, RBC Bioscience Corporation maintains its headquarters in New Taipei City, Taiwan.
Share Price
$0.61578607
Last synced: 2026-11-10
Market Cap
$8.79M
Change (1 day)
-1.94%
Change (1 year)
8.75%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade RBC Bioscience Corporation (6848)
Category
Healthcare
EPS for RBC Bioscience Corporation (6848)
EPS as of June 2026 TTM: $0.05
According to RBC Bioscience Corporation's latest financial reports, its current EPS (TTM) is $0.05. At the end of 2025 the company had an EPS of $0.05, equal to its 2024 EPS of $0.05.
EPS history for RBC Bioscience Corporation from 2018 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.05 | -8.60% |
| 2025 | $0.05 | 14.35% |
| 2024 | $0.05 | 182.21% |
| 2023 | $0.02 | 71.58% |
| 2022 | $0.01 | -88.08% |
| 2021 | $0.08 | -82.53% |
| 2020 | $0.46 | 645.59% |
| 2019 | $0.06 | 3.38% |
| 2018 | $0.06 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | 34,166.96% |
US
|
|
| $-7.07 | -15,570.46% |
US
|
|
| $-5.29 | -11,675.49% |
AU
|
|
| $12.88 | 28,084.03% |
BE
|
|
| $21.56 | 47,077.24% |
NL
|
Questions about RBC Bioscience Corporation's earnings per share (EPS)
What is RBC Bioscience Corporation's earnings per share (EPS)?
RBC Bioscience Corporation's earnings per share (EPS) over the last twelve months is $0.05, as of Jun 2026.
What was RBC Bioscience Corporation's earnings per share (EPS) in 2025?
In 2025, RBC Bioscience Corporation's earnings per share (EPS) was $0.05, about the same as in 2024 ($0.05).
How has RBC Bioscience Corporation's earnings per share (EPS) changed since 2020?
From 2020 to 2025, RBC Bioscience Corporation's earnings per share (EPS) went from $0.46 to $0.05, an average decline of 35.84% a year.
How does RBC Bioscience Corporation's earnings per share (EPS) compare with similar companies?
RBC Bioscience Corporation's earnings per share (EPS) ($0.05) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.